Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.

Показать другие версии (1)

Interferon-β (IFN-β) drugs are considered to derive their beneficial effects on multiple sclerosis (MS) progression via their antiinflammatory properties, but the precise mechanism of action remains unclear. Here, we sought to discover how IFN-β impacts on inflammation-associated aggravation of MS-l...

Полное описание

Библиографические подробности
Главные авторы:	Serres, S, Bristow, C, de Pablos, R, Merkler, D, Soto, MS, Sibson, N, Anthony, D
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis
по: Serres, S, и др.
Опубликовано: (2013)

Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain
по: Serres, S, и др.
Опубликовано: (2009)

CONTRIBUTION OF PERIPHERAL IL-1BETA EXPRESSION IN THE SYSTEMIC REACTIVATION OF FOCAL MOG-EAE LESIONS IN RAT BRAIN
по: Serres, S, и др.
Опубликовано: (2009)

Interferon beta treatment of multiple sclerosis.
по: Markovitz, D
Опубликовано: (1994)

VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.
по: Serres, S, и др.
Опубликовано: (2011)

Beta-interferons in multiple sclerosis
по: Aggarwal Sourabh, и др.
Опубликовано: (2010-01-01)

PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS
по: Mohamed Rayen Ganouni, и др.
Опубликовано: (2023-10-01)

Reactivation of a focal EAE lesion by a systemic inflammatory response
по: Serres, S, и др.
Опубликовано: (2007)

Functional role of endothelial adhesion molecules in the early stages of brain metastasis.
по: Soto, MS, и др.
Опубликовано: (2014)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
по: Sibley, W, и др.
Опубликовано: (1994)

Detection of primary and secondary brain tumours using molecularly-targeted magnetic resonance imaging
по: Serres, S, и др.
Опубликовано: (2016)

Treatment of multiple sclerosis with interferon beta-1b - Reply
по: Sibley, W, и др.
Опубликовано: (1997)

Treatment of multiple sclerosis with interferon beta-1 b.
по: Abdul-Ahad, A, и др.
Опубликовано: (1997)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
по: Castrop F, и др.
Опубликовано: (2013-09-01)

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines
по: Carlos B. Tauil, и др.
Опубликовано: (2020-12-01)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
по: Sørensen, P, и др.
Опубликовано: (2010)

A cost-utility analysis of interferon beta for multiple sclerosis.
по: Parkin, и др.
Опубликовано: (1998-01-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
по: Masoud Mohammad Malekzadeh, и др.
Опубликовано: (2020-06-01)

THE INFLUENCE OF NEUTRALIZING ANTIBODIES TO INTERFERON-BETA ON PROGRESSION OF MULTIPLE SCLEROSIS
по: V. Yu. Lizhdvoy, и др.
Опубликовано: (2016-07-01)

Levels of circulating cytokines in children with multiple sclerosis with different effectiveness of interferon therapy
по: T. V. Radygina, и др.
Опубликовано: (2024-01-01)

Comparison of MRI signatures in pattern I and II multiple sclerosis models.
по: Serres, S, и др.
Опубликовано: (2009)

Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
по: A. D. Kukushkina, и др.
Опубликовано: (2024-08-01)

Proteotranscriptomic analyses reveal distinct interferon-beta signaling pathways and therapeutic targets in choroidal neovascularization
по: Yuxiang Hu, и др.
Опубликовано: (2023-03-01)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
по: Lampasona, V, и др.
Опубликовано: (2003)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
по: Ebers, G, и др.
Опубликовано: (1997)

Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
по: Dian HE, и др.
Опубликовано: (2014-09-01)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
по: De Caro Maria, и др.
Опубликовано: (2006-12-01)

Beta-interferons in multiple sclerosis: A single center experience in India
по: Gupta Salil, и др.
Опубликовано: (2010-01-01)

Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
по: Ivanović Jovana, и др.
Опубликовано: (2019-01-01)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
по: Elmazny A, и др.
Опубликовано: (2020-03-01)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
по: Cocco E, и др.
Опубликовано: (2015-05-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
по: Ebers, G, и др.
Опубликовано: (1998)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
по: Mark S. Freedman, и др.
Опубликовано: (2024-01-01)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
по: Parry, A, и др.
Опубликовано: (2002)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
по: Parry, A, и др.
Опубликовано: (2003)

Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis
по: E Gibbons, и др.
Опубликовано: (2015-01-01)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
по: Alexandre Xavier, и др.
Опубликовано: (2023-05-01)

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
по: Miraç Ayşen Ünsal
Опубликовано: (2019-03-01)

The Effect of Beta Interferon on the Expression of miR-145 in Patients with Multiple Sclerosis
по: Naeim Ehtesham, и др.
Опубликовано: (2016-11-01)

Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
по: Keivan Basiri, и др.
Опубликовано: (2012-02-01)